Angiodynamics (ANGO) Operating Expenses (2010 - 2026)

Angiodynamics has reported Operating Expenses for 17 years, with the latest figure at $54.4 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 11.47% year-over-year to $54.4 million; the trailing twelve-month figure through Feb 2026 stood at $205.9 million (up 1.6% YoY), and the FY2025 full-year result was $197.7 million, down 50.79% from the prior year.
• Operating Expenses for Q1 2026 stood at $54.4 million, up from $50.9 million in the prior quarter.
• The five-year high for Operating Expenses was $242.4 million in Q1 2024, with the low at $43.9 million in Q1 2022.
• Historically, Operating Expenses has averaged $63.5 million across 5 years, with a median of $52.9 million in 2022.
• Annual changes were most pronounced in 2024 — Operating Expenses surged 390.4% — and 2025, when it slumped 79.86%.
• Angiodynamics' Operating Expenses stood at $53.2 million in 2022, then gained by 0.36% to $53.4 million in 2023, then dropped by 4.46% to $51.0 million in 2024, then decreased by 0.18% to $50.9 million in 2025, then rose by 6.92% to $54.4 million in 2026.
• The last three Operating Expenses figures came in at $54.4 million (Q1 2026), $50.9 million (Q4 2025), and $52.5 million (Q3 2025), per Business Quant data.